What is Lucentis (Ranibizumab)?
Lucentis is a prescription medication containing ranibizumab which is designed to be administered via injection into the eyes. It stops the action of vascular endothelial growth factor A which is one of the main culprits in new abnormal blood vessel formation in the eyes that contribute to various eye diseases. Lucentis is supplied in single-use prefilled syringes that provide 0.05ml for intravitreal injection at a concentration of 10mg/ml.
What is it used for?
Lucentis is used in patients diagnosed with neovascular (wet) age-related macular degeneration, macular edema after retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularization.
Why use Lucentis?
Multiple studies were performed in verifying the efficiency of Lucentis. One study compared 222 patients receiving Lucentis to 55 patients who did not receive Lucentis for myopic choroidal neovascularization. At the end of the three-month study, 40% more patients receiving treatment with Lucentis improved by having the ability to see 15 or more letters on an eye chart. For patients with retinal vein occlusion, a six-month study of 263 people found that there were 61% experienced an improvement when treated with Lucentis.
Patients can opt for three monthly treatments leading to less frequent dosing over time, as opposed to continuous monthly dosing. For patients with myopic choroidal neovascularization, monthly treatments are given for up to three months and then as needed. Other indications are usually treated with monthly injections.Click to read more Click to read less
Be the first to review “Lucentis Prefilled Syringe 10mg/ml 0.05ml”
Reviews by verified customers who have purchased this product.